Extreme prematurity: Factors associated with perinatal management and morbi-mortality in western Normandy, France

J Gynecol Obstet Hum Reprod. 2024 Mar;53(3):102735. doi: 10.1016/j.jogoh.2024.102735. Epub 2024 Jan 26.

Abstract

Background: Extreme prematurity (birth before 26 weeks of gestation), presents complex challenges and can lead to various complications. Survival rates of extremely preterm infants are lower in France than in other countries. The choice between active and palliative care is decisive in managing these births.

Objective: To conduct an observational study focused on factors associated with perinatal management, mortality, and morbidity outcomes among extremely preterm births in a regional perinatal network.

Methods: We undertook a retrospective, multicenter study within the western Normandy perinatal network, encompassing live births between 230/6 and 256/6 weeks from 2015 to 2019. Data were extracted from the perinatal network database and medical records.

Results: One hundred and seven infants born from 94 women were included. In the antenatal period, 79 were exposed to corticosteroids, 66 to magnesium sulfate, and 67 to antibiotics. Active care at birth was provided to 84 neonates of whom 42 survived. In total, 65 infants died. Among the 42 surviving neonates, 9 experienced no severe morbidity, 29 displayed one and 4 exhibited two criteria of severe morbidity. Active care was associated with gestational age. Neonatal survival was correlated with antenatal exposure to antibiotics and magnesium sulfate as well as with postnatal corticosteroids. We found no significant association between mortality and gestational age at birth.

Conclusion: Prognostic factors must be weighed to discuss active antenatal care which is crucial for survival of extremely preterm neonates. Cooperation between obstetricians and neonatal caregivers is a cornerstone on a regional perinatal network scale.

Keywords: Active care; Extreme prematurity; Extremely preterm births; Neonatal mortality; Perinatal management; Perinatal morbidity.

Publication types

  • Observational Study
  • Multicenter Study

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Bacterial Agents
  • Female
  • France / epidemiology
  • Humans
  • Infant
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Magnesium Sulfate* / therapeutic use
  • Pregnancy
  • Retrospective Studies

Substances

  • Magnesium Sulfate
  • Anti-Bacterial Agents
  • Adrenal Cortex Hormones